Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
Adnan MalikMuhammad MalikShahbaz Qureshi
Published in: Canadian liver journal (2024)
Silymarin treatment significantly reduces biochemical and transaminase levels in patients with MASLD.